Tech Company Financing Transactions
Transcripta Bio Funding Round
BlueYard Capital, JAZZ Venture Partners and Mayo Clinic participated in a $24 million venture round for Transcripta Bio. The funding round was announced on 7/23/2026.
Transaction Overview
Company Name
Announced On
7/23/2026
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
1804 Embarcadero Rd 201
Palo Alto, CA 94303
USA
Palo Alto, CA 94303
USA
Phone
Undisclosed
Website
Email Address
Overview
Charting a faster path in drug discovery to create better lives for people around the world. With data from hundreds of millions of experiments, we have mapped the effects of thousands of compounds on gene expression to discover new therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Moxham
Vice President
Nicole Perfito
VP - Engineering
Clayton Mellina
VP - Human Resources
Deanna Wong
Browse more venture capital transactions:
Prev: 7/23/2026: telli technologies venture capital transaction
Next: 7/23/2026: Corgi venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs